FOCUS ON LOBULAR BREAST CANCER Front Cover News thanks to Collaborative Research from The European Lobular Breast Cancer Consortium http://www.elbcc.org Congratulations from #ILC Patient Community Invasive lobular carcinoma (ILC) is the most common ‘‘special type’’ breast cancer (BC) worldwide. ILC often has larger tumors on presentation and a unique pattern of metastatic spread compared to…
You are invited to participate in a survey focused on Invasive Lobular Breast Cancer (ILC) which was developed by an international group of researchers, clinicians and breast cancer advocates. The survey was approved by the University of Pittsburgh IRB. It will take approximately 10 mins to complete. If you can please complete the survey no later April 30, 2022. Follow…
The City of Utrecht and The European Lobular Breast Cancer Consortium will play host to the 2022 International ELBCC Lobsterpot Lobular Breast Cancer Symposium and Summerschool Full Agenda can be found at this link https://ilcsymposium2022.com/ There will be a two hour Patient Advocate led Session on Tuesday 21st where we look forward to meeting, many…
Leigh Pate founded The LBCA – Lobular Breast Cancer Alliance along with Professor Steffi Oesterrich, Lori Petitti, Diane Mapes #Lobmob It’s a real success story for Lobular Breast Cancer and an extraordinary example of what a group of ordinary women achieved through collaborative efforts with ILC Researchers and a real, shared, passionate desire for change.Thank…
When I was Diagnosed with Lobular Breast Cancer, 6 years ago there was NO Lobular Specific information available to patients. That is now changed, Lobular Ireland and I are so proud to be a very small part in making this change. Not all #BreastCancer is the same, it’s so important to know this. Signs and…
Access to full article ✅ HERE How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research Lobular Ireland and founder Siobhán Freeney are extremely honoured to be named co author on this Paper and will continue to raise awareness and education around Invasive Lobular Breast Cancer in Ireland and across Europe. Simple Summary…
Breast Cancers are not all the same! Invasive Lobular Breast Cancer is the 2nd most common type of Breast Cancer and it is 6th most common type of Cancer in women overall. It is not often spoken about openly and sometimes women do not understand just how different this type of Breast Cancer is. 15%…
I just want to highlight some of the ILC Advocacy work that I’ve been involved closely with this year so far as Patient Advocate with http://www.Lobularireland.com and http://www.elbcc.org A real highlight has been our association with the recently published paper How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer As founder member of Lobular Ireland…
Another huge milestone for Lobular Ireland and European Lobular Breast Cancer Research and Advocacy Kudos to the Lead Authors for their personal time and commitment to getting this paper published. It’s an real honour to have our name on this Scientific Paper. To share this space with esteemed ILC Scientists, Researchers and other Patient Advocates.…
Researchers, Clinicians, Patients, Patient Advocates, Scientists – Registration is open for #Lobular2021 For Registration and Program of Events http://ilcsymposium.com/ This year’s ILC Symposium has a stellar program of events for anyone interested in learning more about Lobular Breast Cancer. Register now for the #Lobular2021 Symposium 24th – 25th June Lobular Ireland are delighted to be…
We’re very excited to see the new Patient Information Leaflet be finalised. Here’s a sneak peak at what’s coming, it’s still in the final stages, but shouldn’t be more than a couple more weeks. Looking forward to sharing with you. Developing this leaflet has been driven by ELBCC (European Lobular Breast Cancer Consortium) with patent…
Lobular Ireland 